Stay updated on N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Sign up to get notified when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.

Latest updates to the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page
- Check4 days agoChange DetectedThe N-acetylcysteine depression-trial record is displayed with study and participant information, including a recruiting location in Tianjin, China. The record also includes outcome measures, study dates, and an undecided plan for sharing individual participant data.SummaryDifference46%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check25 days agoChange DetectedAn NIH-wide notice appears above the page, announcing a website transition and explaining that some NIH content may use “Super Intelligence” instead of “Artificial Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label updates from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe error page content and Home button disappear, leaving the study record area blank rather than showing clinical-trial details.SummaryDifference0.5%

Stay in the know with updates to N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the N-Acetyl Cysteine in Therapy Refractory Depression Clinical Trial page.